We’re pleased to welcome a new independent director, Laura Hamill, to the Jazz Board of Directors. Learn more: https://lnkd.in/eBDRrCPb
About us
Jazz Pharmaceuticals plc (Nasdaq: JAZZ), is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. We are focused on developing life-changing medicines for people with serious diseases—often with limited or no options—so they can live their lives more fully. By transforming biopharmaceutical discoveries into novel medicines, we are working to give people around the world the opportunity to redefine what’s possible – to make the “small wins” big again. Founded in 2003 and headquartered in Dublin, Ireland, Jazz Pharmaceuticals has a significant corporate presence in Palo Alto, CA and Philadelphia, PA and in England in London, Oxford and Cambridge, with manufacturing facilities in Ireland, England and Italy. We maintain a highly collaborative culture where employees focus on how they can be successful and accomplish positive results by exemplifying the company’s core values: integrity, collaboration, passion, innovation and the pursuit of excellence. Together, we are experts, analysts, specialists, advocates, scientists and professionals all with diverse backgrounds and perspectives. Working together, we are proud to support patients, innovate and bring new medicines to patients with critical unmet needs. Please see our website at www.jazzpharma.com for more information. For information on recruitment, please visit https://careers.jazzpharma.com/. For guidelines on engaging with Jazz on social media, please visit https://bit.ly/2OaMOuq.
- Website
-
http://www.jazzpharma.com
External link for Jazz Pharmaceuticals
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Dublin
- Type
- Public Company
- Founded
- 2003
- Specialties
- Biopharmaceutical , innovation, research and development , great place to work, neuroscience , epilepsy, sleep disorders, oncology, and hematology
Locations
Employees at Jazz Pharmaceuticals
Updates
-
At Jazz, creating a great work experience for employees allows us to better serve our patients. Our EVP and Chief People Officer Heidi Manna spoke to David Green 🇺🇦 on the #DigitalHRLeaders podcast about the employee experience at Jazz and what makes us so unique, including our flexible working model, Jazz Remix. Heidi shared four elements of our people strategy and talked about the importance of really listening to employees, including how continuous dialogue helps to shape our working policies. https://lnkd.in/eBxWFHRJ #GreatPlacetoWork
-
#WorldBrainDay serves as a rallying point to increase education and advocacy efforts to help ensure that every individual has the knowledge and resources to prioritize and maintain their brain health. Today, we join the World Federation of Neurology and our global communities in the effort to champion quality neurology and promote brain health for all. Through strategic global advocacy partnerships, we continuously strive to better our understanding of patients’ needs in order to advance research around complex neurological disorders and develop medicines that are truly meaningful for people living with these conditions. By spreading awareness and fostering collaborations, we can collectively pave the way for a healthier future for those impacted.
-
We’re pleased to announce that Samantha Pearce, Senior Vice President, Europe and International, has been promoted to Chief Commercial Officer effective August 1, 2024. With over 30 years of commercial experience in the pharmaceutical industry, Sam is an inspiring leader who will help us to drive continued transformational growth for our global commercial business in support of our mission to deliver pioneering medicines for people living with serious diseases.
-
-
Our 2023 Corporate Sustainability and Social Impact (CSSI) Report is now live here: https://bit.ly/3zmqaqZ Our values anchor our corporate strategy and support our commitment to generating positive outcomes for patients, employees and other stakeholders. In 2023, we emphasized strengthening the governance of our CSSI strategy to ensure we can deliver positive impact across our key pillars. We will continue to strive for sustainable growth and enhanced value while focusing on reducing our environmental footprint and furthering our capabilities as a responsible and innovative biopharmaceutical company.
-
Now Live: Explore our revamped careers website and discover exciting opportunities to join our team! We've updated the experience to make it easier than ever to learn about working at Jazz and find your next career opportunity. Visit the new site at https://lnkd.in/gYBrm6SW
-
-
We’re at the 2024 ESMO - European Society for Medical Oncology Gastrointestinal Cancers Congress to present our latest data and contribute to greater understanding of difficult-to-treat #GastrointestinalCancers, such as biliary tract cancer (BTC). Although BTC accounts for less than 1% of all adult cancers, an estimated 35,000 people are diagnosed in Europe every year. Hear from our VP of Medical Affairs Europe & International, Tomas Skacel, on the need for greater awareness and early recognition of BTC, and for healthcare professionals onsite at #ESMOGI24 this week, visit us at booth #31.
-
Today, on International #DravetAwarenessDay, we are supporting charities, families and organizations around the world in raising awareness of #DravetSyndrome (DS). DS is a rare, severe and lifelong form of epilepsy that usually begins in the first year of life and leads to some level of developmental disability and dependency on caregivers. Isabella Brambilla, Chairperson of Dravet Italia Onlus, discusses the broader impact of DS on family life, drawing on her own experience caring for her son, who lives with the condition. Your local Dravet Syndrome foundation, such as Dravet Italia Onlus, is a great place to go to access resources for those living with DS, or visit the Dravet Syndrome Foundation.
-
Something new is on the horizon! Our careers website and jobs feed are undergoing renovations until June 26th and will be temporarily unavailable. We appreciate your patience during this time. Please check back after June 26th to explore our updated careers experience and discover exciting job opportunities! If you would like to be notified when the site is live, please email [email protected].
-
-
In celebration of #Juneteenth, we welcomed Dr. Damon Tweedy, M.D., renowned professor of psychiatry and behavioral sciences at Duke University Medical Center and staff physician at the Durham VA Medical Center, to share his personal experiences and insights on healthcare inequities in the U.S. Dr. Tweedy has written extensively about the intersection of race, medicine and mental health and we are honored to have had this opportunity to learn firsthand from him to commemorate this holiday.
-